BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38291436)

  • 1. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
    Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.
    Yuan Q; Zhang J; Liu Y; Chen H; Liu H; Wang J; Niu M; Hou L; Wu Z; Chen Z; Zhang J
    J Pathol; 2022 Apr; 256(4):414-426. PubMed ID: 34927243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization.
    Yuan Q; Gu J; Zhang J; Liu S; Wang Q; Tian T; Chen Z; Zhang J
    Cell Rep; 2021 Feb; 34(5):108724. PubMed ID: 33535045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
    Mohs A; Kuttkat N; Otto T; Youssef SA; De Bruin A; Trautwein C
    Carcinogenesis; 2020 Apr; 41(2):171-181. PubMed ID: 30770929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization.
    Wang B; Li X; Hu W; Zhou Y; Din Y
    IUBMB Life; 2019 Dec; 71(12):1952-1961. PubMed ID: 31408278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Transcription of
    Gou Y; Yang D; Tian T; Zhu X; Zhang R; Ren J; Tu D; Luo Y; Miao Y; Zhao H; Wang Y; Wei B
    Front Immunol; 2022; 13():725595. PubMed ID: 35371096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.
    Zhang J; Liu Y; Chen H; Yuan Q; Wang J; Niu M; Hou L; Gu J; Zhang J
    Cell Death Dis; 2022 Apr; 13(4):411. PubMed ID: 35484116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCOA5 Haploinsufficiency in Myeloid-Lineage Cells Sufficiently Causes Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Zhang Y; Luo Y; Liu X; Kiupel M; Li A; Wang H; Mi QS; Xiao H
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):1-27. PubMed ID: 37734594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
    BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    de Oliveira S; Houseright RA; Graves AL; Golenberg N; Korte BG; Miskolci V; Huttenlocher A
    J Hepatol; 2019 Apr; 70(4):710-721. PubMed ID: 30572006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response.
    Yang B; Luo W; Wang M; Tang Y; Zhu W; Jin L; Wang M; Wang Y; Zhang Y; Zuo W; Huang LJ; Zhao Y; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2022 Oct; 1868(10):166480. PubMed ID: 35811033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.
    Liang Y; Zhang R; Biswas S; Bu Q; Xu Z; Qiao L; Zhou Y; Tang J; Zhou J; Zhou H; Lu L
    Cell Prolif; 2024 Apr; 57(4):e13576. PubMed ID: 37994257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice.
    Hymel E; Vlock E; Fisher KW; Farazi PA
    PLoS One; 2022; 17(8):e0272623. PubMed ID: 35994501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
    Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
    Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
    Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
    Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
    Yang J; Xing Z
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.